Sell alert! Why this expert is calling time on CBA and Woodside shares

A top analyst foresees mounting headwinds for CBA and Woodside shares.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Commonwealth Bank of Australia (ASX: CBA) and Woodside Energy Group Ltd (ASX: WDS) shares have both been strong performers over the past year.

CBA shares closed Monday trading for $183.20 each, while Woodside stock ended the day changing hands for $34.15 a share.

This sees the CBA share price up 16.47% over 12 months, while Woodside shares have gained a whopping 72.04%.

For some context, the S&P/ASX 200 Index (ASX: XJO) is up 15.20% over this same period.

And the above outperformance doesn't include the two fully-franked dividends CBA and Woodside both paid out over the full year.

Woodside trades on a fully franked trailing dividend yield of 4.8%, while CBA shares trade on a fully-franked yield of 2.7%.

But after their recent strong runs, Shaw and Partners' Jed Richards believes now could be an opportune time for stockholders to take some profits off the table (courtesy of The Bull).

Time to sell written on a clock.

Image source: Getty Images

Have Woodside shares burned too bright?

"This energy giant has historically struggled to consistently meet market expectations," said Richards, who has a sell recommendation on Woodside shares. "While the current commodity environment has supported its share price, we see this as an opportunity to exit."

Among potential looming headwinds for the ASX 200 energy stock, Richards noted, "Capital intensity, project execution risk and long dated development timelines remain my concerns."

Richards concluded:

Investors may want to consider taking advantage of its recent valuation and improved sentiment. The shares rose from $23.59 on January 9 to $35.80 on April 7. The shares were trading at $33.37 on April 9. The shares are also responding to volatile crude oil prices resulting from the Middle East conflict.

Which brings us to…

Are CBA shares looking pricey?

Atop Woodside shares, Richards also recommends investors consider selling CBA shares.

"The CBA remains a high-quality banking operation, but its valuation is increasingly difficult to justify," he said. "The stock trades at a significant premium to global peers despite a mature domestic banking market and limited growth potential, in my view."

CBA trades at a price-to-earnings (P/E) ratio of just under 30 times.

Summarising his sell recommendation on CBA shares, Richards concluded:

While earnings remain stable, we see better value elsewhere in the sector. We believe the current share price leaves little margin for error, supporting a sell recommendation on valuation grounds. The shares have risen from $158.74 on February 10 to trade at $181.65 on April 9.

Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

Man drawing an upward line on a bar graph symbolising a rising share price.
Broker Notes

Broker says this ASX 200 stock could rocket 50%+ in 12 months

Bell Potter has good things to say about this stock.

Read more »

Broker Notes

2 ASX 200 stocks drawing fresh buy ratings this week 

These shares have solid upside.

Read more »

Time to sell written on a clock.
Broker Notes

Sell alert! Why this expert is calling time on Magellan and Ramsay Health Care shares

A leading expert forecasts growing headwinds for Magellan and Ramsay Health Care shares. But why?

Read more »

Pilot on the phone looking distraught.
Broker Notes

Sell alert! Why this expert is ditching Qantas shares for this ASX 200 defence stock

A leading expert is selling Qantas shares and buying this surging ASX 200 defence stock instead. But why?

Read more »

Medical workers examine an x-ray or scan in a hospital laboratory.
Broker Notes

Up 64%, 3 reasons this expert predicts Pro Medicus shares will keep on giving

A leading expert forecasts more outperformance from the surging Pro Medicus share price.

Read more »

Business man marking buy on board and underlining it.
Broker Notes

Leading brokers name 3 ASX shares to buy today

Brokers believe that now could be the time to buy these shares.

Read more »

A scientist in a white coat and glasses puts her arms in the air in a sign of strength and success.
Broker Notes

Morgans tips a 600%+ return for this ASX biotech stock

Good clinical study progress has the broker bullish on this company.

Read more »

Wlorker on a laptop on top of solar panels.
Broker Notes

Up 8%, should I buy the rebound in Origin Energy shares today?

A leading analyst provides his forecast for Origin Energy’s rebounding shares.

Read more »